Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376994 · ClinicalTrials.gov registry record · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
A Phase 3 study of Chronic Obstructive Pulmonary Disease (COPD), sponsored by JHSPH Center for Clinical Trials.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 770
- Enrollment target
- 11
- Study locations
NCT06376994 is a Phase 3 study of Chronic Obstructive Pulmonary Disease (COPD) that is actively recruiting participants, run by JHSPH Center for Clinical Trials. The registered enrollment target is 770 participants, above the 630-participant average among 36 other Chronic Obstructive Pulmonary Disease (COPD) trials with a reported enrollment target (22% higher). The trial reports 11 study locations across 9 states.
The verdict
NCT06376994, a Phase 3 study of Chronic Obstructive Pulmonary Disease (COPD), is actively recruiting participants, sponsored by JHSPH Center for Clinical Trials.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 770 participants
- Enrollment target
- 11
- Study locations
Study Summary
This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.
Conditions Studied
Interventions
- DEVICE Air cleaner
- DEVICE Sham air cleaner
Study Locations (11)
Maryland
- University of Maryland - Baltimore
- Johns Hopkins - Baltimore
- Tidal Health - Salisbury
Alabama
- University of Alabama, Lung Health Center - Birmingham
California
- University of California, Los Angeles - Los Angeles
Iowa
- University of Iowa - Iowa City
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Michigan
- University of Michigan - Ann Arbor
New Hampshire
- Dartmouth Hitchcock - Lebanon
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 770 participants |
| Start Date | 2024-05-24 |
| Est. Completion | 2029-11-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06376994
The ClinicalTrials.gov registry entry for NCT06376994 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 770 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 630-participant average among 36 other Chronic Obstructive Pulmonary Disease (COPD) trials with a reported enrollment target (22% higher). The listed sponsor is JHSPH Center for Clinical Trials, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease (COPD) appearing as the primary indexed condition, and to 2 interventions - of which Air cleaner is the first listed.
NCT06376994 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Maryland, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT06376994 about?
NCT06376994 is a clinical study titled "Multi-Center Clean Air Randomized Controlled Trial in COPD". This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.
What is the current status of trial NCT06376994?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 770 participants. The study started on 2024-05-24. Estimated completion is 2029-11-30.
What conditions does trial NCT06376994 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease (COPD).
What interventions are being tested in trial NCT06376994?
The interventions under investigation include: Air cleaner (DEVICE), Sham air cleaner (DEVICE).
Who is sponsoring clinical trial NCT06376994?
This trial is sponsored by JHSPH Center for Clinical Trials, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06376994 being conducted?
This trial has 11 study locations across Alabama, California, Iowa, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease (COPD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RECRUITING · Phase 3
-
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
ACTIVE NOT RECRUITING · Phase 3
-
Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.